Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000505141 | SCV001239235 | pathogenic | Retinal dystrophy | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001857213 | SCV002152547 | pathogenic | not provided | 2023-12-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu296Cysfs*4) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is present in population databases (rs764759172, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with Stargardt disease (PMID: 21911583, 27739528, 28947085). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 438109). For these reasons, this variant has been classified as Pathogenic. |
NIHR Bioresource Rare Diseases, |
RCV000505141 | SCV000599026 | pathogenic | Retinal dystrophy | 2015-01-01 | no assertion criteria provided | research | |
Department of Clinical Genetics, |
RCV000787527 | SCV000926495 | likely pathogenic | Stargardt disease | 2018-04-01 | no assertion criteria provided | research | |
Department of Clinical Genetics, |
RCV000787781 | SCV000926789 | pathogenic | Progressive cone dystrophy (without rod involvement) | 2018-04-01 | no assertion criteria provided | research |